Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Silo Pharma (SILO) Return on Capital Employed (2019 - 2025)

Silo Pharma's Return on Capital Employed history spans 7 years, with the latest figure at 0.19% for Q3 2025.

  • For Q3 2025, Return on Capital Employed rose 37.0% year-over-year to 0.19%; the TTM value through Sep 2025 reached 0.19%, up 37.0%, while the annual FY2024 figure was 0.08%, 35.0% up from the prior year.
  • Return on Capital Employed for Q3 2025 was 0.19% at Silo Pharma, down from 0.18% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.08% in Q4 2024 and bottomed at 1.0% in Q1 2021.
  • The 5-year median for Return on Capital Employed is 0.3% (2022), against an average of 0.39%.
  • The largest annual shift saw Return on Capital Employed skyrocketed 400bps in 2021 before it decreased -24bps in 2024.
  • A 5-year view of Return on Capital Employed shows it stood at 0.26% in 2021, then fell by -16bps to 0.3% in 2022, then crashed by -67bps to 0.51% in 2023, then surged by 85bps to 0.08% in 2024, then tumbled by -143bps to 0.19% in 2025.
  • Per Business Quant, the three most recent readings for SILO's Return on Capital Employed are 0.19% (Q3 2025), 0.18% (Q2 2025), and 0.13% (Q1 2025).